Gilde Investment Management
Gilde Healthcare closes fourth buyout fund on EUR 517m
Double the size of its predecessor, the new vehicle was oversubscribed and saw nearly all Gilde’s existing LPs investing
Novo, Sanofi lead $83m round for Lava Therapeutics
Corporate venture firms were joined by new and existing investors, including Gilde Healthcare
Gilde Healthcare V close on $450m hard-cap
Legal advice was provided by a team from Jones Day led by partner Quirine Eenhorst
Mentha buys and merges Paradigma and BlijWerkt
Gilde Healthcare was invested in HR specialist BlijWerkt since 2011
Gilde Healthcare closes third fund on €200m
Gilde Healthcare Services III targets healthcare providers based in the Benelux and DACH regions
LSP leads $28m round for Lumeon
Healthcare software company will expand its US operations and invest in marketing
Gilde Healthcare sells NightBalance to Royal Philips
Philips expands its sleep and respiratory care portfolio through the acquisition
Gilde Healthcare exits Stat-DX
Gilde Healthcare led a €31m funding round for molecular diagnostic specialist Stat-DX in 2016
Gilde Equity Management buys conTeyor in SBO
GP takes over from Down2Earth in backing the Belgian recycling and packaging business
Gilde Healthcare’s Rad-X buys TelradKo
Acquisition will provide TelradKo with fresh capital to accelerate its expansion
Agic, Capvis, Gilde, Nordic Capital in final Amann Girrbach round
Nordic Capital is reportedly the front-runner in the sale of the Austrian dental prosthetics company
Private debt funds expand market share in Germany
Growing use of use of first-out, second-out unitranche leads to private debt funds more than doubling their share of German mid-market deals
Gilde sells Synbra to trade for €117.5m
Sale ends an 18-year holding period for Gilde, which acquired the company in 1999
Gilde Healthcare-backed Rad-x buys SMII
Gilde Healthcare began its buy-and-build strategy in this sector in January 2017
Gilde acquires Performation in MBO
GP acquires a majority stake in the Dutch healthcare business-intelligence provider
Gilde sells Viroclinics to Parcom Capital
Gilde sells the Dutch contract research organisation after a four-year holding period
PE-backed Rad-x bolts on Acura
Deal marks the second bolt-on for the business, following the acquisition of Swiss diagnostic imaging provider IRD
Gilde Buy Out Partners sells HG International to Cobepa
GP had taken over the group from sister firm Gilde Equity Management in 2013
Usual suspects working hard in sedate Benelux market
Trend of declining dealflow in the region shows little signs of change, though buyout multiples return towards lower long-term averages
Gilde leads €25m series-C for Stat-Diagnostica
Backers include Kurma Partners, Ysios Capital, Idinvest Partners, Caixa Capital Risc and others
VC-backed Acacia to list in October
Offering size understood to lie around the £150m mark
VC-backed Ascendis raises $108m in IPO
Listing priced at $18 per share
Fund in focus: Gilde Healthcare closes GHS II on €100m
Managing partner Jasper van Gorp shares details with unquote"
Ascendis completes $60m series-D
A total of seven investors comitted capital to the round